Literature DB >> 29097062

Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.

Edmund Cheong1, Lizzie Dodd2, William Smith2, Timothy Kleinig2.   

Abstract

Severe orolingual angioedema is a life-threatening complication of alteplase treatment for acute ischemic stroke that occurs during alteplase infusion or in the first 2 hours afterward. Currently, there are no proven therapies, although glucocorticoids, antihistamines, and adrenaline are sometimes used. Intubation is required if significant airway compromise supervenes. The incidence is .2%-5.1%, and risk factors include treatment with angiotensin-converting enzyme inhibitors and total insular infarcts. Here we report a case of alteplase-induced severe angioedema, which resolved briskly following icatibant treatment.
Copyright © 2018 National Stroke Association. All rights reserved.

Entities:  

Keywords:  Stroke; allergy; alteplase; angioedema; icatibant; thrombolysis

Mesh:

Substances:

Year:  2017        PMID: 29097062     DOI: 10.1016/j.jstrokecerebrovasdis.2017.09.039

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  2 in total

1.  Incidence of orolingual angioedema after intravenous thrombolysis for stroke.

Authors:  Bruno Censori; T Partziguian; V Bonito; M Sgarzi; R Riva; D Alimonti; E Agazzi; M Vedovello; B Frigeni; E Venturelli; S La Gioia; V Barcella; L Daleffe; L Longhi; F Ferri; R Cosentini; M R Rottoli
Journal:  Neurol Sci       Date:  2018-08-06       Impact factor: 3.307

Review 2.  Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection.

Authors:  Steven de Maat; Quirijn de Mast; A H Jan Danser; Frank L van de Veerdonk; Coen Maas
Journal:  Semin Thromb Hemost       Date:  2020-06-11       Impact factor: 4.180

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.